Exact Mass: 610.2425
Exact Mass Matches: 610.2425
Found 446 metabolites which its exact mass value is equals to given mass value 610.2425
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Candesartan cilexetil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].
Mycobilin a
Mycobilin b
Endomorphin-1
Endomorphin-1 (H-Tyr-Pro-Trp-Phe-NH2) and endomorphin-2 (H-Tyr-Pro-Phe-Phe-NH2) are peptide amides with the highest known affinity and specificity for the mu-opioid receptor. [HMDB] Endomorphin-1 (H-Tyr-Pro-Trp-Phe-NH2) and endomorphin-2 (H-Tyr-Pro-Phe-Phe-NH2) are peptide amides with the highest known affinity and specificity for the mu-opioid receptor. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 has antinociceptive properties[1][2][4]. Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 has antinociceptive properties[1][2][4].
Rhodin G7
Rhodin G7 is a chlorin derivatives. Natural-chlorophyll-related porphyrins, including (2H, Zn, Cu)-protoporphyrin IX (Por-1) and Zn-mesoporphyrin IX (Por-2), and chlorins, including chlorin e₆ (Chl-1), chlorin e₄ (Chl-2), and rhodin G₇ (Chl-3), have been used in dye-sensitized solar cells (DSSCs). (PMID 22504833)
5-O-[2-(4-Benzhydrylpiperazin-1-yl)ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-3,4-dihydropyridine-3,5-dicarboxylate
manidipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Carboxypeptidase B
Hydrolase is a member of the class of compounds known as oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. Hydrolase is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Hydrolase can be found in cocoa bean, which makes hydrolase a potential biomarker for the consumption of this food product. In biochemistry, a hydrolase is an enzyme that catalyzes the hydrolysis of a chemical bond. For example, an enzyme that catalyzes the following reaction is a hydrolase: A–B + H2O → A–OH + B–H .
divinylchlorophyllide a
Divinylchlorophyllide a is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Divinylchlorophyllide a can be found in a number of food items such as wild rice, pecan nut, vaccinium (blueberry, cranberry, huckleberry), and black-eyed pea, which makes divinylchlorophyllide a a potential biomarker for the consumption of these food products.
6,10-Diacetoxy-4,5-di(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzooxepin-7,9-diol
10-Acetoxy-5a-(acetoxymethyl)-5,7-di(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-6,9-diol
[3S-(3alpha,4beta,5alpha,5aalpha,6alpha,9beta,9aalpha,10S*)]-5a-[(Acetyloxy)methyl]octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-4,5,6,9,10-pentol, 5-acetate 4,6-dibenzoate
manidipine
C - Cardiovascular system > C08 - Calcium channel blockers > C08C - Selective calcium channel blockers with mainly vascular effects > C08CA - Dihydropyridine derivatives C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
(1R,2S,4S,5S,6R,7R,8S,9R,10S)-1,8-diacetoxy-6,9-dibenzoyloxy-2,4-dihydroxydihydro-beta-agarofuran
(1S,4aS,5R,7S,7aS)-7-(acetyloxy)-1-[(6-O-alpha-D-galactopyranosyl-beta-D-glucopyranosyl)oxy]-1,4a,5,6,7,7a-hexahydro-5-hydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester|6-O-alpha-D-galactopyranosylbarlerin
1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxy-tax-11-ene|1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxytax-11-ene
1S,13-Diacetyloxy-4S-hydroxy-6R-(3-)furancarbonyloxy-9S-cinnamoyloxy-??-dihydroagarofuran
8,10-Diacetoxy-5,6-di(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzooxepin-7,9-diol
1??,9??-Dihydroxy-4??,20-epoxy-2??,5??,7??,10??,13??-penta-acetoxytax-11-ene
3,4-Dihydroxyphenylethanol-8-O-[??-D-apiofuranosyl(1鈥樏傗垎3)-??-D-glucopyranosyl(1鈥樏傗垎6)]-??-D-glucopyranoside
7,10-Diacetoxy-5,6-di(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzooxepin-8,9-diol
14-desoxo-3-O-propionyl-5-O-acetyl-7-O-benzoyl-myrsinol-14beta-acetate
3-hydroxy-4,5-dimethoxyphenyl 6-O-{(2E,4E)-5-[(1R,3S,5S,8S)-3,8-dihydroxy-1,5-dimethyl-7-oxo-6-oxabicyclo[3.2.1]oct-8-yl]-3-methylpenta-2,4-dienoyl}-beta-D-glucopyranoside|litseaglutinan A
6alpha,13-bis(acetyloxy)-9beta-(cinnamoyloxy)-1beta-[(furan-3-ylcarbonyl)oxy]-4alpha-hydroxy-beta-dihydroagarofuran|furan-3-carboxylic acid (3R,5R,5aS,6S,9S,9aS,10R)-10-(acetyloxy)-5a-[(acetyloxy)methyl]-octahydro-9-hydroxy-2,2,9-trimethyl-2H-3,9a-methano-1-benzoxepin-6-yl ester
Orbiculin I
A dihydroagarofuran sesquiterpenoid that consists of dihydro-beta-agarofuran substituted by an acetoxy group at position 1 and furoyloxy groups at positions 2, 6 and 9 (the 1beta,2beta,6alpha,9alpha stereoisomer). Isolated from Celastrus orbiculatus, it exhibits inhibition of both NF-kappaB activation and nitric oxide production.
Hexa-Me ether-4,7-Dihydroxyflavanone(3鈥樏傗垎3)-2,4,4,6-tetrahydroxychalcone
3-(3-hydroxy-5-methoxyphenyl)-N-[2-(4-hydroxyphenyl)ethyl]-7-[(1E)-3-{[2-(4-hydroxyphenyl)ethyl]amino}-3-oxoprop-1-en-1-yl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide
3,3-[4,4-dimethyl-2,2-dioxo-2,5,2,5-tetrahydro-5,5-(3,9-dimethyl-8-vinyl-4,5-dihydro-dipyrrolo[1,2-a;2,3-d]azepine-2,7-diylbismethylene)-di-pyrrol-3-yl]-bis-propionic acid dimethyl ester|Phorcabilin-dimethylester
10-Acetoxy-5a-(acetoxymethyl)-5,6-di(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-4,9-diol
1beta-acetoxyl-2beta,6alpha,9alpha-trifuroyloxydihydro-beta-agarofuran|orbiculin I
10-Acetoxy-5a-(acetoxymethyl)-4,5-di(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-6,9-diol
5-Acetoxy-5a-(acetoxymethyl)-4,6-di(benzoyloxy)-3,4,5,5a,6,7,8,9-octahydro-2,2,9-trimethyl-2H-3,9a-methano-1-benzooxepin-9,10-diol
Methyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate
Methyl 1,4-bisglucosyloxy-3-prenyl-2-naphthoate is a natural product found in Wollastonia biflora, Indocypraea montana, and Galium mollugo with data available.
7,15-O-diacetyl-5-O-benzoyl-3-propanoyl-13,17-oxy-14-oxopremyrsinol
C29H38O14_Methyl 1,4-bis(beta-D-glucopyranosyloxy)-3-(3-methyl-2-buten-1-yl)-2-naphthoate
methyl 3-(3-methylbut-2-enyl)-1,4-bis[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]naphthalene-2-carboxylate
methyl 3-(3-methylbut-2-enyl)-1,4-bis[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]naphthalene-2-carboxylate_major
Cys Phe Arg Trp
Cys Phe Trp Arg
Cys Arg Phe Trp
Cys Arg Trp Phe
Cys Trp Phe Arg
Cys Trp Arg Phe
Cys Tyr Tyr Tyr
Asp Lys Trp Tyr
Asp Lys Tyr Trp
Asp Gln Trp Tyr
Asp Gln Tyr Trp
Asp Trp Lys Tyr
Asp Trp Gln Tyr
Asp Trp Tyr Lys
Asp Trp Tyr Gln
Asp Tyr Lys Trp
Asp Tyr Gln Trp
Asp Tyr Trp Lys
Asp Tyr Trp Gln
Glu His Tyr Tyr
Glu Asn Trp Tyr
Glu Asn Tyr Trp
Glu Trp Asn Tyr
Glu Trp Tyr Asn
Glu Tyr His Tyr
Glu Tyr Asn Trp
Glu Tyr Trp Asn
Glu Tyr Tyr His
Phe Cys Arg Trp
Phe Cys Trp Arg
Phe Met Gln Trp
Phe Met Trp Gln
Phe Gln Met Trp
Phe Gln Trp Met
Phe Arg Cys Trp
Phe Arg Trp Cys
Phe Trp Cys Arg
Phe Trp Met Gln
Phe Trp Gln Met
Phe Trp Arg Cys
Gly Trp Trp Tyr
Gly Trp Tyr Trp
Gly Tyr Trp Trp
His Glu Tyr Tyr
His Tyr Glu Tyr
His Tyr Tyr Glu
Lys Asp Trp Tyr
Lys Asp Tyr Trp
Lys Trp Asp Tyr
Lys Trp Tyr Asp
Lys Tyr Asp Trp
Lys Tyr Trp Asp
Met Phe Gln Trp
Met Phe Trp Gln
Met Gln Phe Trp
Met Gln Trp Phe
Met Trp Phe Gln
Met Trp Gln Phe
Asn Glu Trp Tyr
Asn Glu Tyr Trp
Asn Trp Glu Tyr
Asn Trp Tyr Glu
Asn Tyr Glu Trp
Asn Tyr Trp Glu
Gln Asp Trp Tyr
Gln Asp Tyr Trp
Gln Phe Met Trp
Gln Phe Trp Met
Gln Met Phe Trp
Gln Met Trp Phe
Gln Trp Asp Tyr
Gln Trp Phe Met
Gln Trp Met Phe
Gln Trp Tyr Asp
Gln Tyr Asp Trp
Gln Tyr Trp Asp
Arg Cys Phe Trp
Arg Cys Trp Phe
Arg Phe Cys Trp
Arg Phe Trp Cys
Arg Ser Trp Tyr
Arg Ser Tyr Trp
Arg Trp Cys Phe
Arg Trp Phe Cys
Arg Trp Ser Tyr
Arg Trp Tyr Ser
Arg Tyr Ser Trp
Arg Tyr Trp Ser
Ser Arg Trp Tyr
Ser Arg Tyr Trp
Ser Trp Arg Tyr
Ser Trp Tyr Arg
Ser Tyr Arg Trp
Ser Tyr Trp Arg
Trp Cys Phe Arg
Trp Cys Arg Phe
Trp Asp Lys Tyr
Trp Asp Gln Tyr
Trp Asp Tyr Lys
Trp Asp Tyr Gln
Trp Glu Asn Tyr
Trp Glu Tyr Asn
Trp Phe Cys Arg
Trp Phe Met Gln
Trp Phe Gln Met
Trp Phe Arg Cys
Trp Gly Trp Tyr
Trp Gly Tyr Trp
Trp Lys Asp Tyr
Trp Lys Tyr Asp
Trp Met Phe Gln
Trp Met Gln Phe
Trp Asn Glu Tyr
Trp Asn Tyr Glu
Trp Gln Asp Tyr
Trp Gln Phe Met
Trp Gln Met Phe
Trp Gln Tyr Asp
Trp Arg Cys Phe
Trp Arg Phe Cys
Trp Arg Ser Tyr
Trp Arg Tyr Ser
Trp Ser Arg Tyr
Trp Ser Tyr Arg
Trp Trp Gly Tyr
Trp Trp Tyr Gly
Trp Tyr Asp Lys
Trp Tyr Asp Gln
Trp Tyr Glu Asn
Trp Tyr Gly Trp
Trp Tyr Lys Asp
Trp Tyr Asn Glu
Trp Tyr Gln Asp
Trp Tyr Arg Ser
Trp Tyr Ser Arg
Trp Tyr Trp Gly
Tyr Cys Tyr Tyr
Tyr Asp Lys Trp
Tyr Asp Gln Trp
Tyr Asp Trp Lys
Tyr Asp Trp Gln
Tyr Glu His Tyr
Tyr Glu Asn Trp
Tyr Glu Trp Asn
Tyr Glu Tyr His
Tyr Gly Trp Trp
Tyr His Glu Tyr
Tyr His Tyr Glu
Tyr Lys Asp Trp
Tyr Lys Trp Asp
Tyr Asn Glu Trp
Tyr Asn Trp Glu
Tyr Gln Asp Trp
Tyr Gln Trp Asp
Tyr Arg Ser Trp
Tyr Arg Trp Ser
Tyr Ser Arg Trp
Tyr Ser Trp Arg
Tyr Trp Asp Lys
Tyr Trp Asp Gln
Tyr Trp Glu Asn
Tyr Trp Gly Trp
Tyr Trp Lys Asp
Tyr Trp Asn Glu
Tyr Trp Gln Asp
Tyr Trp Arg Ser
Tyr Trp Ser Arg
Tyr Trp Trp Gly
Tyr Tyr Cys Tyr
Tyr Tyr Glu His
Tyr Tyr His Glu
Tyr Tyr Tyr Cys
Endomorphin-1
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 has antinociceptive properties[1][2][4]. Endomorphin 1, a high affinity, highly selective agonist of the μ-opioid receptor (Ki: 1.11 nM), displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM. Endomorphin 1 has antinociceptive properties[1][2][4].
1,3,3-trimethyl-2-(2-(2-phenyl-3-(2-(1,3,3-trimethyl-1h-2(3h)- indolidene)ethylidene)-1-cyclopentenyl)ethenyl)-3h-indolium perchlorate
1,3-BIS(BIS((1H-BENZO[D]IMIDAZOL-2-YL)METHYL)AMINO)PROPAN-2-OL
2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil
2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil
Triptofordin C 2
A dihydroagarofuran sesquiterpenoid that is isolated from Tripterygium wilfordii.
2-Carbomethoxy-3-prenyl-1,4-naphthohydroquinone-di-O-beta-D-glucoside
3-[2-[(E)-[(5E)-3-(2-carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-2-ylidene]methyl]-5-(4-ethenyl-5-formyl-3-methyl-1H-pyrrole-2-carbonyl)-4-methyl-2H-pyrrol-3-yl]propanoic acid
3-[(2E,5E)-2-[[3-(2-carboxyethyl)-5-(3-ethenyl-5-formyl-4-methyl-1H-pyrrole-2-carbonyl)-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid
3-[(21S,22S)-11-ethyl-4-hydroxy-16-(1-hydroxyethyl)-3-methoxycarbonyl-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
3-[(11R,12R,21S,22S)-11-ethyl-16-(1-hydroxyethylidene)-3-methoxycarbonyl-12,17,21,26-tetramethyl-4-oxo-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1(23),2,5,8(26),9,13(25),14,17,19-nonaen-22-yl]propanoic acid
3-[(11E,12R,21S,22S)-11-ethylidene-4-hydroxy-16-(1-hydroxyethyl)-3-methoxycarbonyl-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,13,15(24),16,18,20(23)-decaen-22-yl]propanoic acid
Arg-Trp-Ser-Tyr
A tetrapeptide composed of L-arginine, L-tryptophan, L-serine, and L-tyrosine joined in sequence by peptide linkages.
(3aR,10bR)-5-[2-(benzenesulfonyl)ethyl]-2-[4-(3-hydroxypropoxy)phenyl]-3a-(phenylmethyl)-6,10b-dihydrooxazolo[4,5-d][2]benzazepin-4-one
1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-(4-methylphenyl)sulfonylamino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
4-[[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
4-[[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
3-methoxy-N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
4-[[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
1-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
4-[[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl-methylamino]methyl]benzoic acid
1-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(1-naphthalenyl)urea
1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(1-naphthalenyl)urea
3-methoxy-N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
3-methoxy-N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
[1-acetyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
[(1R,2R,3R,4S,5S,7R,8S,9R,10R,14R)-2,14-diacetyloxy-7-hydroxy-5,9-dimethyl-4-propanoyloxy-11-prop-1-en-2-yl-16-oxatetracyclo[7.5.2.01,10.03,7]hexadec-12-en-8-yl] benzoate
Candesartan cilexetil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].
3-[(2Z,5Z)-2-[[3-(2-carboxyethyl)-5-(3-ethenyl-5-formyl-4-methyl-1H-pyrrole-2-carbonyl)-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(4-ethenyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid
3-[(2Z,5Z)-2-[[3-(2-Carboxyethyl)-5-(4-ethenyl-5-formyl-3-methyl-1H-pyrrole-2-carbonyl)-4-methyl-1H-pyrrol-2-yl]methylidene]-5-[(3-ethenyl-4-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid
N-acetyl-beta-D-glucosaminyl-1,6-(N-acetyl-beta-D-glucosaminyl-1,3)-N-acetyl-D-galactosaminyl group
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-oxo-4-(tritylamino)butanoic acid
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-oxo-4-(tritylamino)butanoic acid is an asparagine derivative[1].
(1's,2r,2's,3'r,5's,7's,8's,9'r,10'r,13's)-2',7',9',10'-tetrakis(acetyloxy)-1',13'-dihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-5'-yl acetate
(1's,2s,2's,3'r,5's,7's,8's,9'r,10'r,13's)-2',5',9',10'-tetrakis(acetyloxy)-1',13'-dihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-7'-yl acetate
methyl 7-(acetyloxy)-5-hydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-4-carboxylate
(1r,2s,5r,6r,10s,13r,14s,16s)-13-(acetyloxy)-6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-11-en-14-yl (2z)-2-methylbut-2-enoate
(1r,2r,3r,4s,5r,7r,8r,9s,10s,11s,12z,14r,17s)-2,7,10-tris(acetyloxy)-5,9-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-11-yl butanoate
(1's,2s,2's,3'r,5's,7's,8's,9'r,10'r,13's)-2',5',9',10'-tetrakis(acetyloxy)-1',7'-dihydroxy-8',12',15',15'-tetramethylspiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-13'-yl acetate
13-(acetyloxy)-6-(furan-3-yl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-11-en-14-yl 2-methylbut-2-enoate
2,7,9-tris(acetyloxy)-5,10-dihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadec-12-en-11-yl butanoate
(1s,2s,3s,4s,5r,6s,7s,9r,12r)-3,12-bis(acetyloxy)-7-(benzoyloxy)-2,4-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-5-yl benzoate
(1s,2s,3r,4s,7r,9s,10s,11r,12r,15s)-2,11,12,15-tetrakis(acetyloxy)-1,4-dihydroxy-10,14,17,17-tetramethyl-6-oxatetracyclo[11.3.1.0³,¹⁰.0⁴,⁷]heptadec-13-en-9-yl acetate
2,5,9,11-tetrakis(acetyloxy)-8-hydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-16-yl acetate
(1s,2s,3s,4r,5r,6s,7s,9r,12r)-4,12-bis(acetyloxy)-5-(benzoyloxy)-2,3-dihydroxy-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxytax-11-ene
{"Ingredient_id": "HBIN002376","Ingredient_name": "1beta,7beta-dihydroxy-4beta,20-epoxy-2alpha,5alpha,9alpha,10beta,13alpha-pentaacetoxytax-11-ene","Alias": "1\u03b2,7\u03b2-dihydroxy-4\u03b2,20-epoxy-2\u03b1,5\u03b1,9\u03b1,10\u03b2,13\u03b1-pentaacetoxytax-11-ene","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25904;5880","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1beta,9alpha-dihydroxy-4beta,20-epoxy-2alpha,5alpha,7beta,10beta,13alpha-penta-acetoxytax-11-ene
{"Ingredient_id": "HBIN002377","Ingredient_name": "1beta,9alpha-dihydroxy-4beta,20-epoxy-2alpha,5alpha,7beta,10beta,13alpha-penta-acetoxytax-11-ene","Alias": "1\u03b2,9\u03b1-dihydroxy-4\u03b2,20-epoxy-2\u03b1,5\u03b1,7\u03b2,10\u03b2,13\u03b1-penta-acetoxytax-11-ene","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)OC(=O)C)C)O)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25903;5881","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1beta-hydroxy-7beta-deacetyoxy-1alpha-hydroxybaccatin i
{"Ingredient_id": "HBIN002404","Ingredient_name": "1beta-hydroxy-7beta-deacetyoxy-1alpha-hydroxybaccatin i","Alias": "NA","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C4(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)CO4)OC(=O)C)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31175","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1β-hydroxy-7β-deacetyoxy-7α-hydroxybaccatini
{"Ingredient_id": "HBIN002405","Ingredient_name": "1\u03b2-hydroxy-7\u03b2-deacetyoxy-7\u03b1-hydroxybaccatini","Alias": "NA","Ingredient_formula": "C30H42O13","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9964","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,4-dihydroxyphenylethanol-8-o-[β-d-apiofu-ranosyl(1→3)-β-d-glucopyranosyl(1→6)]-β-d-glucopyranoside
{"Ingredient_id": "HBIN007418","Ingredient_name": "3,4-dihydroxyphenylethanol-8-o-[\u03b2-d-apiofu-ranosyl(1\u21923)-\u03b2-d-glucopyranosyl(1\u21926)]-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C25H38O17","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6077","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
4-deacetylbaccatin iv
{"Ingredient_id": "HBIN010309","Ingredient_name": "4-deacetylbaccatin iv","Alias": "NA","Ingredient_formula": "C30H42O13","Ingredient_Smile": "CC1=C2C(C(C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C)O)OC(=O)C)(CO4)O)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "610.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4723","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101670647","DrugBank_id": "NA"}
atractyloside a 14-o-β-d-fructofuranoside
{"Ingredient_id": "HBIN017301","Ingredient_name": "atractyloside a 14-o-\u03b2-d-fructofuranoside","Alias": "NA","Ingredient_formula": "C27H46O15","Ingredient_Smile": "CC1(C2CC(CCC(C2CC1=O)(COC3(C(C(C(O3)CO)O)O)CO)O)C(C)(C)OC4C(C(C(C(O4)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14418","TCMID_id": "1974","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}